U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07762729) titled 'Gut Microbiota and Metabolic Development in Early Childhood: A 3-Year Follow-Up Study' on J... Read More
U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07762365) titled 'Brain Stimulation Paired With Structured Reading Instruction in Children With Dyslexia' on ... Read More
U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07763522) titled 'Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Qu... Read More
U.S., Aug. 14 -- ClinicalTrials.gov registry received information related to the study (NCT07762742) titled 'A Comparative Study of Percutaneous Pulsed Field Ablation Guided by Ultrasound Alone Versus... Read More
Singapore, Aug. 14 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Phase 3 Study of Rina-S ± Bevacizumab Versus Investigator's Choice of Pl... Read More
Singapore, Aug. 14 -- The Health Sciences Authority received information related to the study titled 'An Open-Label, Rollover Study for Participants with Thyroid Eye Disease Previously Enrolled in Amg... Read More
Singapore, Aug. 14 -- The Health Sciences Authority received information related to the study titled 'An Open-Label Study to Investigate the Long-Term Effects of Acoramidis on Cardiac Function, Struct... Read More
Singapore, Aug. 14 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Open-Label, Randomized, Crossover Study to Investigate the Relative Bioavailability of ... Read More
Singapore, Aug. 14 -- The Health Sciences Authority received information related to the study titled 'Solid tumor Study for Long term Treatment of Cancer Patients Who Have Participated in BMS-Parent S... Read More
Singapore, Aug. 14 -- The Health Sciences Authority received information related to the study titled 'A Global, Multicentre, Phase II Platform Study of Datopotamab Deruxtecan (Dato-DXd)-based Combinat... Read More